Seattle, Washington
United States
4
2024-03-28
4
2025-01-14
These are the the leading inventors for applications assigned to OncoResponse, Inc.:
OncoResponse, Inc. based in Seattle, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Immunomodulatory antibodies and methods of use thereof
#2 | 2022-09-15 ✅ Patent 11,634,501 granted on 2023-04-25Immunomodulatory antibodies and methods of use thereof
#3 | 2021-08-19 ✅ Patent 11,827,715 granted on 2023-11-28Human CD163 antibodies and uses thereof
#4 | 2021-02-18 ✅ Patent 11,034,770 granted on 2021-06-15Immunomodulatory antibodies and methods of use thereof
Also check out OncoResponse, Inc.'s (Seattle, United States) applicant profile with 9 patent applications submitted.
589927 ⎘